Minerva gastroenterology最新文献

筛选
英文 中文
Pediatric gastroenteritis: an integrated analysis of epidemiology, clinical manifestations, diagnostic methods, and multi-level therapeutic interventions. 小儿肠胃炎:流行病学、临床表现、诊断方法和多层次治疗干预的综合分析。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-18 DOI: 10.23736/S2724-5985.24.03739-2
Xuejing Geng, Xiansheng Cao, Wei Zhou, Jixiang Jiang, Xue Zhou, Hong Liu
{"title":"Pediatric gastroenteritis: an integrated analysis of epidemiology, clinical manifestations, diagnostic methods, and multi-level therapeutic interventions.","authors":"Xuejing Geng, Xiansheng Cao, Wei Zhou, Jixiang Jiang, Xue Zhou, Hong Liu","doi":"10.23736/S2724-5985.24.03739-2","DOIUrl":"https://doi.org/10.23736/S2724-5985.24.03739-2","url":null,"abstract":"","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study. 监测接受生物制剂治疗的炎症性肠病患者的心理病理特征:一项试点研究。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-18 DOI: 10.23736/S2724-5985.24.03719-7
Antonio M D'Onofrio, Lodovico M Balzoni, Gaspare F Ferrajoli, Federica DI Vincenzo, Daniele Napolitano, Elisa Schiavoni, Georgios D Kotzalidis, Alessio Simonetti, Marianna Mazza, Ilenia Rosa, Mauro Pettorruso, Gabriele Sani, Antonio Gasbarrini, Franco Scaldaferri, Giovanni Camardese
{"title":"Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study.","authors":"Antonio M D'Onofrio, Lodovico M Balzoni, Gaspare F Ferrajoli, Federica DI Vincenzo, Daniele Napolitano, Elisa Schiavoni, Georgios D Kotzalidis, Alessio Simonetti, Marianna Mazza, Ilenia Rosa, Mauro Pettorruso, Gabriele Sani, Antonio Gasbarrini, Franco Scaldaferri, Giovanni Camardese","doi":"10.23736/S2724-5985.24.03719-7","DOIUrl":"https://doi.org/10.23736/S2724-5985.24.03719-7","url":null,"abstract":"<p><strong>Background: </strong>Biological agents were found to alter the psychopathological profile of a small subgroup of patients treated for a variety of conditions, including inflammatory bowel disease (IBD) and psychiatric disorders. The association between the administration of biological agents and psychopathology needs to be further investigated.</p><p><strong>Methods: </strong>In this naturalistic prospective cohort study, patients with IBD were assigned to two treatment groups, i.e., a biological agent (which also included tofacitinib) or conventional therapy. Clinician-administered scales were used to assess psychosomatic symptoms (Hamilton Depression Rating Scale [Ham-D], Hamilton Anxiety Rating Scale [Ham-A], Young Mania Rating Scale [YMRS], and Brief Psychiatric Rating Scale [BPRS]) and disease activity (Mayo Score and Harvey-Bradshaw Index [HBI]) at baseline, after one, three, and six months of treatment. Each group was assessed for the course of their scores during the observation period at each assessment point.</p><p><strong>Results: </strong>Patients on biological drugs who completed three months of treatment (N.=32) and six months of treatment (N.=20) scored significantly lower on the Mayo compared to baseline. Patients on conventional treatment obtained significant drops from baseline on the HBI after one and three months of treatment (N.=30) and also at the six-month endpoint (N.=11). Both groups showed no improvement or worsening on the psychiatric rating scales.</p><p><strong>Conclusions: </strong>In this study, we found no evidence of psychiatric symptom worsening, as some literature would suggest. Our data suggest that the use of biological agents in IBD is safe.</p>","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements and applications of plant-based fish oil soft capsules. 植物性鱼油软胶囊的进展和应用。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-05 DOI: 10.23736/S2724-5985.24.03736-7
Xiangting Meng, Bin Shi, Min Yin, Kailin Guan, Yunhui Lai, Zitong Yan, Huaying Fan, Dunwei He
{"title":"Advancements and applications of plant-based fish oil soft capsules.","authors":"Xiangting Meng, Bin Shi, Min Yin, Kailin Guan, Yunhui Lai, Zitong Yan, Huaying Fan, Dunwei He","doi":"10.23736/S2724-5985.24.03736-7","DOIUrl":"https://doi.org/10.23736/S2724-5985.24.03736-7","url":null,"abstract":"","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of mesalazine suppository combined with Kangfuxin solution retention enema on inflammatory markers and adverse reactions in patients with active ulcerative colitis. 美沙拉秦栓剂联合康复欣溶液保留灌肠对活动性溃疡性结肠炎患者炎症指标和不良反应的影响
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-05 DOI: 10.23736/S2724-5985.24.03720-3
Fan Xie, Yan Zhang, Tianye Wang
{"title":"Effects of mesalazine suppository combined with Kangfuxin solution retention enema on inflammatory markers and adverse reactions in patients with active ulcerative colitis.","authors":"Fan Xie, Yan Zhang, Tianye Wang","doi":"10.23736/S2724-5985.24.03720-3","DOIUrl":"https://doi.org/10.23736/S2724-5985.24.03720-3","url":null,"abstract":"","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the molecular mechanisms of castor oil extract in regulating host cell MAPK signaling pathway to inhibit herpes simplex virus type 1 infection. 探索蓖麻油提取物调节宿主细胞 MAPK 信号通路以抑制 1 型单纯疱疹病毒感染的分子机制。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-05 DOI: 10.23736/S2724-5985.24.03737-9
Chang Liu, Rui Qin, Zhenhua Zhang, Rui Ma
{"title":"Exploring the molecular mechanisms of castor oil extract in regulating host cell MAPK signaling pathway to inhibit herpes simplex virus type 1 infection.","authors":"Chang Liu, Rui Qin, Zhenhua Zhang, Rui Ma","doi":"10.23736/S2724-5985.24.03737-9","DOIUrl":"https://doi.org/10.23736/S2724-5985.24.03737-9","url":null,"abstract":"","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical analysis of painless gastroscopic high-frequency electrocoagulation and electrosurgery for gastric polyp treatment: a scientific perspective. 无痛胃镜下高频电凝电切治疗胃息肉的临床分析:科学视角。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-12-21 DOI: 10.23736/S2724-5985.23.03570-2
Yuan Chu, Jiangtao Li
{"title":"Clinical analysis of painless gastroscopic high-frequency electrocoagulation and electrosurgery for gastric polyp treatment: a scientific perspective.","authors":"Yuan Chu, Jiangtao Li","doi":"10.23736/S2724-5985.23.03570-2","DOIUrl":"10.23736/S2724-5985.23.03570-2","url":null,"abstract":"","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"392-395"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138833782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver involvement in presence of heart disease and heart involvement in presence of liver disease: a conundrum. 肝脏受累同时伴有心脏疾病和心脏受累同时伴有肝脏疾病:一个难题。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2024-01-24 DOI: 10.23736/S2724-5985.23.03589-1
Paolo Costa, Gian M Rosa, Gianni Testino, Ulrico Dorighi, Italo Porto
{"title":"Liver involvement in presence of heart disease and heart involvement in presence of liver disease: a conundrum.","authors":"Paolo Costa, Gian M Rosa, Gianni Testino, Ulrico Dorighi, Italo Porto","doi":"10.23736/S2724-5985.23.03589-1","DOIUrl":"10.23736/S2724-5985.23.03589-1","url":null,"abstract":"<p><p>Data from literature show a cross-talk between the heart and liver during diseases which primarily involve one of the two organs, but data regarding this relationship are scant. Aim of this study was to investigate this relationship. In this narrative review we critically explored the most recent literature on this topic using PubMed and Medline and examining the most recent studies about liver involvement in heart failure and heart involvement in course of liver disease. Patients with acute and chronic heart failure and those who undergo heart transplatation (HT) manifest various signs of liver damage with a rate of incidence which is higher in candidates for left ventricular assist device. In presence of cardiogenic shock a very marked hepatocellular necrosis may occur while in the setting of chronic heart failure congestive hepatopathy and-or the so-called cardiac cirrhosis are observed. On the other side in presence of chronic liver disease and in case of liver transplantation (LT) heart functions may be altered and cirrhotic cardiomyopathy, which is a syndrome characterized by systolic, diastolic and electrophysiological abnormalities may occur. In this review we have analyzed the relationship between heart and liver disease, even in case of LT and HT. Furthermore we have underscored the effects of chronic alcoholism and of systemic disorders such as hemochromatosis and amyloidosis on both heart and liver.</p>","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"359-373"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139543839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges and solutions in laparoscopy for super obese gynecological patients: an elderly endometrial cancer patient. 腹腔镜治疗超肥胖妇科患者的挑战和解决方案:一名老年子宫内膜癌症患者。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-10-02 DOI: 10.23736/S2724-5985.23.03525-8
Haixia Liang, Lichun Niu, Jie Cheng, Jinge Li, Huifang Song, Ying Zhang, Xuejing Zhao, Kui Zhang
{"title":"Challenges and solutions in laparoscopy for super obese gynecological patients: an elderly endometrial cancer patient.","authors":"Haixia Liang, Lichun Niu, Jie Cheng, Jinge Li, Huifang Song, Ying Zhang, Xuejing Zhao, Kui Zhang","doi":"10.23736/S2724-5985.23.03525-8","DOIUrl":"10.23736/S2724-5985.23.03525-8","url":null,"abstract":"","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"387-390"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41144203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis. 质子泵抑制剂用于提示后患者的肝性脑病:一项系统综述和荟萃分析。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-10-27 DOI: 10.23736/S2724-5985.23.03422-8
Manesh K Gangwani, Zohaib Ahmed, Rizwan Ishtiaq, Muhammad Aziz, Anooja Rani, Dushyant S Dahiya, Fnu Priyanka, Syeda F Arif, Wade Lee-Smith, Amir H Sohail, Sumant Inamdar, Mona Hassan
{"title":"Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis.","authors":"Manesh K Gangwani, Zohaib Ahmed, Rizwan Ishtiaq, Muhammad Aziz, Anooja Rani, Dushyant S Dahiya, Fnu Priyanka, Syeda F Arif, Wade Lee-Smith, Amir H Sohail, Sumant Inamdar, Mona Hassan","doi":"10.23736/S2724-5985.23.03422-8","DOIUrl":"10.23736/S2724-5985.23.03422-8","url":null,"abstract":"<p><strong>Introduction: </strong>Hepatic encephalopathy (HE) after Trans-jugular intrahepatic portosystemic shunt (TIPS) is a common clinical problem. According to recent studies, Proton pump inhibitor (PPI) use can serve as an independent risk factor for HE. We performed a systematic review and meta-analysis to analyze the association between HE with PPI use versus without PPI use in patients undergoing TIPS.</p><p><strong>Evidence acquisition: </strong>We conducted a comprehensive literature search from inception through February 15<sup>th</sup>, 2022 on MEDLINE, EMBASE, Cochrane Register of Controlled Trials, and Web of Science databases. Odds ratio (OR) was calculated when comparing dichotomous variables of patients with HE vs. no HE in PPI use versus no PPI use in post TIPS patients. A 95% confidence interval (CI) and P values (<0.05 considered significant) were also generated.</p><p><strong>Evidence synthesis: </strong>The search strategy yielded a total of 27 articles. We finalized four studies with a total of 825 patients. There was statistically significant difference in TIPS patients with HE in PPI users versus non-PPI users (OR 3.39 [1.79-6.43], P<0.01, I<sup>2</sup>=55.5%). Pooled mean average days to hospitalization was 215.2 days to hospitalization for hepatic encephalopathy in non-PPI users compared to 139.5 days in PPI users.</p><p><strong>Conclusions: </strong>Our study determines that there is a higher risk of post-TIPS HE in patients on PPI therapy vs. patients not receiving PPI therapy. We recommend using PPIs at a lower tolerable dose where necessary. Larger studies are needed to draw stronger conclusions.</p>","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"353-358"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54232973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients. 晚期肝纤维化的预测因素和纤维化评分的表现:瘦型与非瘦型代谢功能障碍相关脂肪变性肝病(MASLD)患者的比较。
IF 1.9
Minerva gastroenterology Pub Date : 2024-09-01 Epub Date: 2023-10-27 DOI: 10.23736/S2724-5985.23.03518-0
Shoham Dabbah, Gil Ben Yakov, Monika-Inda Kaufmann, Oranit Cohen-Ezra, Maria Likhter, Yana Davidov, Ziv Ben Ari
{"title":"Predictors of advanced liver fibrosis and the performance of fibrosis scores: lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients.","authors":"Shoham Dabbah, Gil Ben Yakov, Monika-Inda Kaufmann, Oranit Cohen-Ezra, Maria Likhter, Yana Davidov, Ziv Ben Ari","doi":"10.23736/S2724-5985.23.03518-0","DOIUrl":"10.23736/S2724-5985.23.03518-0","url":null,"abstract":"<p><strong>Background: </strong>Non-alcoholic fatty liver disease (NAFLD) in lean patients differs from that of NAFLD in non-lean patients. However, current data regarding predictors of advanced fibrosis and the performance of fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS) in lean compared to non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients is insufficient.</p><p><strong>Methods: </strong>This was a cross-sectional study. Lean was defined as Body Mass Index <25 kg/m<sup>2</sup>. Advanced fibrosis (F3-F4) was detected by liver biopsy or two-dimension shear wave elastography (2D-SWE). Predictors of advanced fibrosis were identified using logistic regression and area under ROC curves (AUROC) were derived for FIB-4 and NFS.</p><p><strong>Results: </strong>Lean patients (N.=153) comprised 19.2% of the MASLD cohort. Advanced fibrosis was associated with the number of cardiometabolic risk factors (CMRF) in lean (OR=2.06, P=0.011) and non-lean (OR=1.58, P<0.001) patients, however, hypertension and diabetes or impaired fasting glucose were significant only among non-lean. Age was associated with advanced fibrosis in both subgroups with age ≥65 showing higher odds in lean compared to non-lean patients (P=0.016). Non-lean patients had higher odds for advanced fibrosis relative to lean patients (OR=4.8, P=0.048). FIB-4 and NFS predicted advanced fibrosis among lean (AUROC=0.79 and AUROC=0.85, respectively) and non-lean (AUROC=0.79 and AUROC=0.76, respectively) patients. NFS ≥-1.445 showed higher specificity among lean compared to non-lean (P<0.001) and compared to that of FIB-4 ≥1.3 in lean patients (P<0.001).</p><p><strong>Conclusions: </strong>The number of CMRF was predictive of advanced fibrosis in both subgroups while age ≥65 showed higher odds among lean patients. NFS ≥-1.445 is more specific than FIB-4 ≥1.3 for advanced fibrosis prediction in lean patients. These findings may help identify high-risk lean MASLD patients for further liver fibrosis stage assessment.</p>","PeriodicalId":94142,"journal":{"name":"Minerva gastroenterology","volume":" ","pages":"322-331"},"PeriodicalIF":1.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54232974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信